SecBot SecBot
3 ·Filed Apr 1, 2026

TRAX

First Tracks Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001184627-26-000003
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Monitor for subsequent Form 4 or amended Form 3 filings that may disclose actual share quantities and transaction history. This initial filing alone does not indicate insider buying or selling activity.

DirectionNeutral
Confidencelow
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Dennis M. Fenton filed a Form 3 indicating initial beneficial ownership of securities in First Tracks Biotherapeutics, Inc. The filing is a standard disclosure required for insiders and does not include specific details on the number or value of shares held. No material financial or operational information was disclosed.

Key Facts

  • Form 3 filed by Dennis M. Fenton on April 1, 2026, reporting initial beneficial ownership of securities in First Tracks Biotherapeutics, Inc.
  • No specific share amounts, values, or transaction details were included in the available documents.
  • Company previously changed its name from Biopharma Company, Inc. on October 10, 2025.

Financial Impact

undisclosed amount

Risk Factors

  • Lack of disclosed share numbers limits ability to assess insider sentiment.
  • Potential for future disclosures to reveal material ownership changes.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001184627-26-000003
Document: 0001184627-26-000003-index.html0001184627-26-000003
Document: 0001184627-26-000003.txt0001184627-26-000003
20 reports for TRAX
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +30.21%Oct 13, 2026
Filters
Rows
Reports for TRAX — sortable, filterable
TypeNow
Oct 26, 2026
today
S-1
NEUTRAL ★ 4/10
$43.80awaiting T+1—$44.05 (+0.57%)
Oct 20, 2026
5d ago
8-K
NEUTRAL ★ 2/10
$42.77 $43.14▲ +0.87%▲ +2.05%$44.05 (+2.99%)
Oct 15, 2026
10d ago
8-K
BEARISH ★ 6/10
$34.46 $36.28▼ −5.28%▼ −4.86%$44.05 (−27.83%)
Oct 15, 2026
11d ago
Press Release
BEARISH ★ 6/10
$36.04 $34.46▲ +4.38%▲ +3.28%$44.05 (−22.23%)
Oct 13, 2026
13d ago
8-K
BULLISH ★ 7/10
$31.68 $34.13▲ +7.73%▲ +8.81%$44.05 (+39.05%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 6/10
$44.03 $44.04▲ +0.02%▲ +0.22%$44.05 (+0.05%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 6/10
$44.03 $44.04▲ +0.02%▲ +0.22%$44.05 (+0.05%)
Aug 7, 2026
11w ago
3/A
NEUTRAL ★ 2/10
$47.92 $46.75▼ −2.44%▼ −2.12%$44.05 (−8.08%)
Jun 22, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$17.78 $16.69▼ −6.13%▼ −6.08%$44.05 (+147.75%)
May 14, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$16.90 $17.79▲ +5.27%▲ +5.33%$44.05 (+160.65%)
Showing 10 of 20

US Market Status

Market Closed — Opens in 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026